Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 How does interferon-α insult the vasculature? Let me count the ways.

Literature DB >> 21279989

How does interferon-α insult the vasculature? Let me count the ways.

Mariana J Kaplan, Jane E Salmon.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2011 PMID： 21279989 PMCID： PMC3064442 DOI： 10.1002/art.30161

Source DB: PubMed Journal: Arthritis Rheum ISSN： 0004-3591

× No keyword cloud information.

19 in total

1. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.

Authors: Vidya V Kunjathoor; Maria Febbraio; Eugene A Podrez; Kathryn J Moore; Lorna Andersson; Stephanie Koehn; Jeongmi S Rhee; Roy Silverstein; Henry F Hoff; Mason W Freeman
Journal: J Biol Chem Date: 2002-10-09 Impact factor: 5.157

2. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha.

Authors: Alexander Niessner; Kayoko Sato; Elliot L Chaikof; Ines Colmegna; Jörg J Goronzy; Cornelia M Weyand
Journal: Circulation Date: 2006-11-20 Impact factor: 29.690

Review 3. Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

Authors: Jacques Banchereau; Virginia Pascual
Journal: Immunity Date: 2006-09 Impact factor: 31.745

4. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Authors: J M Esdaile; M Abrahamowicz; T Grodzicky; Y Li; C Panaritis; R du Berger; R Côte; S A Grover; P R Fortin; A E Clarke; J L Senécal
Journal: Arthritis Rheum Date: 2001-10

5. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.

Authors: Jing Hua; Kyriakos Kirou; Christina Lee; Mary K Crow
Journal: Arthritis Rheum Date: 2006-06

6. Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus.

Authors: Peter E Westerweel; Remco K M A C Luijten; Imo E Hoefer; Hein A Koomans; Ronald H W M Derksen; Marianne C Verhaar
Journal: Ann Rheum Dis Date: 2007-02-28 Impact factor: 19.103

7. The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.

Authors: Seth G Thacker; Celine C Berthier; Deborah Mattinzoli; Maria Pia Rastaldi; Matthias Kretzler; Mariana J Kaplan
Journal: J Immunol Date: 2010-08-30 Impact factor: 5.422

8. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

Authors: Mary J Roman; Beth-Ann Shanker; Adrienne Davis; Michael D Lockshin; Lisa Sammaritano; Ronit Simantov; Mary K Crow; Joseph E Schwartz; Stephen A Paget; Richard B Devereux; Jane E Salmon
Journal: N Engl J Med Date: 2003-12-18 Impact factor: 91.245

9. Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity.

Authors: Sanjay Rajagopalan; Emily C Somers; Robert D Brook; Christine Kehrer; Dana Pfenninger; Emily Lewis; Anjan Chakrabarti; Bruce C Richardson; Eric Shelden; W Joseph McCune; Mariana J Kaplan
Journal: Blood Date: 2004-01-15 Impact factor: 22.113

10. Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis.

Authors: Michael F Denny; Seth Thacker; Hemal Mehta; Emily C Somers; Todd Dodick; Franck J Barrat; W Joseph McCune; Mariana J Kaplan
Journal: Blood Date: 2007-07-16 Impact factor: 25.476

19 in total

Review 1. Neutrophils in the pathogenesis and manifestations of SLE.

Authors: Mariana J Kaplan
Journal: Nat Rev Rheumatol Date: 2011-09-27 Impact factor: 20.543

2. Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome.

Authors: Robert C Grenn; Srilakshmi Yalavarthi; Alex A Gandhi; Nayef M Kazzaz; Carlos Núñez-Álvarez; Diego Hernández-Ramírez; Antonio R Cabral; W Joseph McCune; Paula L Bockenstedt; Jason S Knight
Journal: Ann Rheum Dis Date: 2016-07-18 Impact factor: 19.103

3. Accelerated atherosclerosis in SLE: mechanisms and prevention approaches.

Authors: Ashley J Wilhelm; Amy S Major
Journal: Int J Clin Rheumtol Date: 2012-10-01

Review 4. Postoperative risk of venous thromboembolism in rheumatic disease patients.

Authors: Lauren E Wong; Anne R Bass
Journal: Curr Rheumatol Rep Date: 2015-02 Impact factor: 4.592

Review 5. The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?

Authors: J Michelle Kahlenberg; Mariana J Kaplan
Journal: Curr Opin Rheumatol Date: 2014-09 Impact factor: 5.006

Review 6. Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases?

Authors: Ashish N Rao; Nayef M Kazzaz; Jason S Knight
Journal: World J Cardiol Date: 2015-12-26

7. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.

Authors: Jason S Knight; Venkataraman Subramanian; Alexander A O'Dell; Srilakshmi Yalavarthi; Wenpu Zhao; Carolyne K Smith; Jeffrey B Hodgin; Paul R Thompson; Mariana J Kaplan
Journal: Ann Rheum Dis Date: 2014-08-07 Impact factor: 19.103